These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 27786478)
1. The Aggregation Free Energy Landscapes of Polyglutamine Repeats. Chen M; Tsai M; Zheng W; Wolynes PG J Am Chem Soc; 2016 Nov; 138(46):15197-15203. PubMed ID: 27786478 [TBL] [Abstract][Full Text] [Related]
2. Study of the aggregation mechanism of polyglutamine peptides using replica exchange molecular dynamics simulations. Nakano M; Ebina K; Tanaka S J Mol Model; 2013 Apr; 19(4):1627-39. PubMed ID: 23288093 [TBL] [Abstract][Full Text] [Related]
3. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease. Chen M; Wolynes PG Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517 [TBL] [Abstract][Full Text] [Related]
5. Biophysical underpinnings of the repeat length dependence of polyglutamine amyloid formation. Landrum E; Wetzel R J Biol Chem; 2014 Apr; 289(15):10254-10260. PubMed ID: 24596088 [TBL] [Abstract][Full Text] [Related]
6. Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Kar K; Jayaraman M; Sahoo B; Kodali R; Wetzel R Nat Struct Mol Biol; 2011 Mar; 18(3):328-36. PubMed ID: 21317897 [TBL] [Abstract][Full Text] [Related]
7. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset. Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and disaggregation of asparagine repeat-containing peptides. Lu X; Murphy RM J Pept Sci; 2014 Nov; 20(11):860-7. PubMed ID: 25044797 [TBL] [Abstract][Full Text] [Related]
9. Assessing polyglutamine conformation in the nucleating event by molecular dynamics simulations. Miettinen MS; Knecht V; Monticelli L; Ignatova Z J Phys Chem B; 2012 Aug; 116(34):10259-65. PubMed ID: 22770401 [TBL] [Abstract][Full Text] [Related]
10. Backbone Engineering within a Latent β-Hairpin Structure to Design Inhibitors of Polyglutamine Amyloid Formation. Kar K; Baker MA; Lengyel GA; Hoop CL; Kodali R; Byeon IJ; Horne WS; van der Wel PC; Wetzel R J Mol Biol; 2017 Jan; 429(2):308-323. PubMed ID: 27986569 [TBL] [Abstract][Full Text] [Related]
11. Exploring the aggregation free energy landscape of the amyloid-β protein (1-40). Zheng W; Tsai MY; Chen M; Wolynes PG Proc Natl Acad Sci U S A; 2016 Oct; 113(42):11835-11840. PubMed ID: 27698130 [TBL] [Abstract][Full Text] [Related]
12. Effects of chain length on the aggregation of model polyglutamine peptides: molecular dynamics simulations. Marchut AJ; Hall CK Proteins; 2007 Jan; 66(1):96-109. PubMed ID: 17068817 [TBL] [Abstract][Full Text] [Related]
13. Why Is Arginine the Only Amino Acid That Inhibits Polyglutamine Monomers from Taking on Toxic Conformations? Tanimoto S; Okumura H ACS Chem Neurosci; 2024 Aug; 15(15):2925-2935. PubMed ID: 39009034 [TBL] [Abstract][Full Text] [Related]
14. Insights into the Aggregation Mechanism of PolyQ Proteins with Different Glutamine Repeat Lengths. Yushchenko T; Deuerling E; Hauser K Biophys J; 2018 Apr; 114(8):1847-1857. PubMed ID: 29694863 [TBL] [Abstract][Full Text] [Related]
15. Early stage aggregation of a coarse-grained model of polyglutamine. Haaga J; Gunton JD; Buckles CN; Rickman JM J Chem Phys; 2018 Jan; 148(4):045106. PubMed ID: 29390859 [TBL] [Abstract][Full Text] [Related]
16. Reconsidering the mechanism of polyglutamine peptide aggregation. Lee CC; Walters RH; Murphy RM Biochemistry; 2007 Nov; 46(44):12810-20. PubMed ID: 17929830 [TBL] [Abstract][Full Text] [Related]